Zhang, X., Zhang, S., Yang, X., Yang, J., Zhou, Q., Yin, L., . . . Wu, Y. (2010). Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. BioMed Central.

Zhang, Xuchao, et al. Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression. BioMed Central, 2010.

Zhang, Xuchao, et al. Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression. BioMed Central, 2010.